Mutation screening of <it>NOS1AP </it>gene in a large sample of psychiatric patients and controls

<p>Abstract</p> <p>Background</p> <p>The gene encoding carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase (<it>NOS1AP</it>) is located on chromosome 1q23.3, a candidate region for schizophrenia, autism spectrum disorders (ASD) and obsessive-compu...

Full description

Bibliographic Details
Main Authors: Nygren Gudrun, Schuroff Franck, Jamain Stéphane, Chaste Pauline, Anckarsäter Henrik, Scheid Isabelle, Betancur Catalina, Delorme Richard, Herbrecht Evelyn, Dumaine Anne, Mouren Marie, Råstam Maria, Leboyer Marion, Gillberg Christopher, Bourgeron Thomas
Format: Article
Language:English
Published: BMC 2010-07-01
Series:BMC Medical Genetics
Online Access:http://www.biomedcentral.com/1471-2350/11/108
_version_ 1819292850885492736
author Nygren Gudrun
Schuroff Franck
Jamain Stéphane
Chaste Pauline
Anckarsäter Henrik
Scheid Isabelle
Betancur Catalina
Delorme Richard
Herbrecht Evelyn
Dumaine Anne
Mouren Marie
Råstam Maria
Leboyer Marion
Gillberg Christopher
Bourgeron Thomas
author_facet Nygren Gudrun
Schuroff Franck
Jamain Stéphane
Chaste Pauline
Anckarsäter Henrik
Scheid Isabelle
Betancur Catalina
Delorme Richard
Herbrecht Evelyn
Dumaine Anne
Mouren Marie
Råstam Maria
Leboyer Marion
Gillberg Christopher
Bourgeron Thomas
author_sort Nygren Gudrun
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>The gene encoding carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase (<it>NOS1AP</it>) is located on chromosome 1q23.3, a candidate region for schizophrenia, autism spectrum disorders (ASD) and obsessive-compulsive disorder (OCD). Previous genetic and functional studies explored the role of <it>NOS1AP </it>in these psychiatric conditions, but only a limited number explored the sequence variability of <it>NOS1AP</it>.</p> <p>Methods</p> <p>We analyzed the coding sequence of <it>NOS1AP </it>in a large population (n = 280), including patients with schizophrenia (n = 72), ASD (n = 81) or OCD (n = 34), and in healthy volunteers controlled for the absence of personal or familial history of psychiatric disorders (n = 93).</p> <p>Results</p> <p>Two non-synonymous variations, V37I and D423N were identified in two families, one with two siblings with OCD and the other with two brothers with ASD. These rare variations apparently segregate with the presence of psychiatric conditions.</p> <p>Conclusions</p> <p>Coding variations of <it>NOS1AP </it>are relatively rare in patients and controls. Nevertheless, we report the first non-synonymous variations within the human <it>NOS1AP </it>gene that warrant further genetic and functional investigations to ascertain their roles in the susceptibility to psychiatric disorders.</p>
first_indexed 2024-12-24T04:01:05Z
format Article
id doaj.art-31eebaf8aa1d456ab3947ef4484e77b8
institution Directory Open Access Journal
issn 1471-2350
language English
last_indexed 2024-12-24T04:01:05Z
publishDate 2010-07-01
publisher BMC
record_format Article
series BMC Medical Genetics
spelling doaj.art-31eebaf8aa1d456ab3947ef4484e77b82022-12-21T17:16:19ZengBMCBMC Medical Genetics1471-23502010-07-0111110810.1186/1471-2350-11-108Mutation screening of <it>NOS1AP </it>gene in a large sample of psychiatric patients and controlsNygren GudrunSchuroff FranckJamain StéphaneChaste PaulineAnckarsäter HenrikScheid IsabelleBetancur CatalinaDelorme RichardHerbrecht EvelynDumaine AnneMouren MarieRåstam MariaLeboyer MarionGillberg ChristopherBourgeron Thomas<p>Abstract</p> <p>Background</p> <p>The gene encoding carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase (<it>NOS1AP</it>) is located on chromosome 1q23.3, a candidate region for schizophrenia, autism spectrum disorders (ASD) and obsessive-compulsive disorder (OCD). Previous genetic and functional studies explored the role of <it>NOS1AP </it>in these psychiatric conditions, but only a limited number explored the sequence variability of <it>NOS1AP</it>.</p> <p>Methods</p> <p>We analyzed the coding sequence of <it>NOS1AP </it>in a large population (n = 280), including patients with schizophrenia (n = 72), ASD (n = 81) or OCD (n = 34), and in healthy volunteers controlled for the absence of personal or familial history of psychiatric disorders (n = 93).</p> <p>Results</p> <p>Two non-synonymous variations, V37I and D423N were identified in two families, one with two siblings with OCD and the other with two brothers with ASD. These rare variations apparently segregate with the presence of psychiatric conditions.</p> <p>Conclusions</p> <p>Coding variations of <it>NOS1AP </it>are relatively rare in patients and controls. Nevertheless, we report the first non-synonymous variations within the human <it>NOS1AP </it>gene that warrant further genetic and functional investigations to ascertain their roles in the susceptibility to psychiatric disorders.</p>http://www.biomedcentral.com/1471-2350/11/108
spellingShingle Nygren Gudrun
Schuroff Franck
Jamain Stéphane
Chaste Pauline
Anckarsäter Henrik
Scheid Isabelle
Betancur Catalina
Delorme Richard
Herbrecht Evelyn
Dumaine Anne
Mouren Marie
Råstam Maria
Leboyer Marion
Gillberg Christopher
Bourgeron Thomas
Mutation screening of <it>NOS1AP </it>gene in a large sample of psychiatric patients and controls
BMC Medical Genetics
title Mutation screening of <it>NOS1AP </it>gene in a large sample of psychiatric patients and controls
title_full Mutation screening of <it>NOS1AP </it>gene in a large sample of psychiatric patients and controls
title_fullStr Mutation screening of <it>NOS1AP </it>gene in a large sample of psychiatric patients and controls
title_full_unstemmed Mutation screening of <it>NOS1AP </it>gene in a large sample of psychiatric patients and controls
title_short Mutation screening of <it>NOS1AP </it>gene in a large sample of psychiatric patients and controls
title_sort mutation screening of it nos1ap it gene in a large sample of psychiatric patients and controls
url http://www.biomedcentral.com/1471-2350/11/108
work_keys_str_mv AT nygrengudrun mutationscreeningofitnos1apitgeneinalargesampleofpsychiatricpatientsandcontrols
AT schurofffranck mutationscreeningofitnos1apitgeneinalargesampleofpsychiatricpatientsandcontrols
AT jamainstephane mutationscreeningofitnos1apitgeneinalargesampleofpsychiatricpatientsandcontrols
AT chastepauline mutationscreeningofitnos1apitgeneinalargesampleofpsychiatricpatientsandcontrols
AT anckarsaterhenrik mutationscreeningofitnos1apitgeneinalargesampleofpsychiatricpatientsandcontrols
AT scheidisabelle mutationscreeningofitnos1apitgeneinalargesampleofpsychiatricpatientsandcontrols
AT betancurcatalina mutationscreeningofitnos1apitgeneinalargesampleofpsychiatricpatientsandcontrols
AT delormerichard mutationscreeningofitnos1apitgeneinalargesampleofpsychiatricpatientsandcontrols
AT herbrechtevelyn mutationscreeningofitnos1apitgeneinalargesampleofpsychiatricpatientsandcontrols
AT dumaineanne mutationscreeningofitnos1apitgeneinalargesampleofpsychiatricpatientsandcontrols
AT mourenmarie mutationscreeningofitnos1apitgeneinalargesampleofpsychiatricpatientsandcontrols
AT rastammaria mutationscreeningofitnos1apitgeneinalargesampleofpsychiatricpatientsandcontrols
AT leboyermarion mutationscreeningofitnos1apitgeneinalargesampleofpsychiatricpatientsandcontrols
AT gillbergchristopher mutationscreeningofitnos1apitgeneinalargesampleofpsychiatricpatientsandcontrols
AT bourgeronthomas mutationscreeningofitnos1apitgeneinalargesampleofpsychiatricpatientsandcontrols